Pharmaceuticals/Life Sciences Operational Transformation

Pharmaceuticals/Life Sciences Operational Transformation

Who is This Market Analysis For?

NelsonHall’s “Pharmaceuticals/Life Sciences Operational Transformation” report is a comprehensive market assessment report designed for:
• Sourcing managers, monitoring the capabilities of existing suppliers of pharmaceuticals/life sciences operational transformation services, and identifying vendor suitability for operational transformation services RFPs
• Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
• Financial analysts and investors specializing in the pharmaceuticals/life sciences services sector.

Key Findings & Highlights

NelsonHall’s Pharmaceuticals/Life Sciences Operational Transformation Report focuses on how vendors delivering industry-specific services to pharmaceuticals/life sciences clients meet their requirements.

Some large organizations already have experience working with leading vendors to support their pharmaceuticals/life sciences operational transformation activities. However, many organizations are now recognizing that they need to introduce changes and undertake widespread transformation programs of their pharmaceuticals and life sciences operational activities, programs that might include reimagining and standardizing processes, enhancing user journeys, utilizing advanced analytics, intelligent automation, AI/ML, and other new technologies.

Scope of the Report

The report analyzes the worldwide market for pharmaceuticals/life sciences operational transformation services and addresses the following questions:
• What is the market size and projected growth for the global pharmaceuticals/life sciences operational transformation services market?
• What are the top drivers for adopting pharmaceuticals/life sciences operational transformation services?
• What are the benefits currently achieved by users of pharmaceuticals/life sciences operational transformation services?
• What factors inhibit user adoption of pharmaceuticals/life sciences operational transformation services?
• What pricing mechanisms are typically used within pharmaceuticals/life sciences operational transformation services?
• What combination of services is typically provided within pharmaceuticals/life sciences operational transformation services contracts, and what new services are being added?
• What is the current pattern of the delivery location used for pharmaceuticals/life sciences operational transformation services, and how is this changing?
• What services are delivered from onshore and which from offshore?
• What are the challenges and success factors within pharmaceuticals/life sciences operational transformation services?